Sector
PharmaceuticalsOpen
₹94Prev. Close
₹94.45Turnover(Lac.)
₹6.13Day's High
₹96.5Day's Low
₹9252 Week's High
₹232.952 Week's Low
₹87.99Book Value
₹59.42Face Value
₹10Mkt Cap (₹ Cr.)
130.86P/E
12.97EPS
7.28Divi. Yield
2.65Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 13.88 | 13.88 | 13.88 | 13.88 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 66.49 | 58.39 | 52.57 | 47.63 |
Net Worth | 80.37 | 72.27 | 66.45 | 61.51 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 109.31 | 136.14 | 107.22 | 113.36 |
yoy growth (%) | -19.7 | 26.97 | -5.41 | 13.76 |
Raw materials | -55.43 | -61.56 | -49.47 | -53.93 |
As % of sales | 50.7 | 45.22 | 46.13 | 47.57 |
Employee costs | -10.58 | -12.2 | -9.46 | -12.56 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 3.08 | 5.72 | 2.03 | 1.96 |
Depreciation | -5.95 | -6.66 | -5.92 | -6.77 |
Tax paid | -0.82 | -1.51 | 0.1 | -0.72 |
Working capital | 1.54 | -1.82 | 5.34 | 11.94 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -19.7 | 26.97 | -5.41 | 13.76 |
Op profit growth | -31.64 | 24.51 | -13.28 | 63.81 |
EBIT growth | -46.15 | 29.53 | -14.37 | 134.25 |
Net profit growth | -46.26 | 96.56 | 73.22 | -127.82 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Dinesh B Patel
Managing Director
Himanshu C Patel
Non Executive Director
Anar H Patel
Independent Director
Hemendrakumar C Shah
Independent Director
HEMANG BHANUPRASAD PATEL
Independent Director
Dipak N Patel
Company Sec. & Compli. Officer
Anal Desai
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Denis Chem Lab Ltd
Summary
Denis Chem Lab Ltd, was incorporated in 1980 and was converted into a Public Limited Company in 1982. The Company was registered with Directorate General of Technical Development (DGTD) for manufacturing 4 million bottles of I.V. Fluids and 75 MT of Bulk Drugs per annum and started commercial production for sterile Intravenous (IV) Injectibles in 1984 and also came up with a rights issue during the year In 1995, it ventured into manufacturing of IV Fluids in PP bottles using BFS technology.The Company is a manufacturer of antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti anaerobic injections, irrigation solutions etc. It is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles. The Company products are manufactured in ultra modern plant using automatic equipments and facilities, which are conforming to GMP specifications as per WHO norms. These products are filled in glass bottles in volume of 100 ml, 250 ml, 500 ml and 1000 ml. in aseptic condition and followed by terminal sterilization. The Company introduced I.V. Fluids facility in plastic bottles using Blow Fill Seal (BFS) technology, which commissioned in 2007-08. It started manufacturing of I.V. Fluids in P.P. Plastic bottles using latest BFS technology with an installed capacity of 15 million units per annum in 2016.In 2018-19, the Company implemented a project with the addition of 100 ml Eurohead products to its Aquapulse B
Read More
The Denis Chem Lab Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹94.3 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Denis Chem Lab Ltd is ₹130.86 Cr. as of 09 May ‘25
The PE and PB ratios of Denis Chem Lab Ltd is 12.97 and 1.59 as of 09 May ‘25
The 52-week high/low is the highest and lowest price at which a Denis Chem Lab Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Denis Chem Lab Ltd is ₹87.99 and ₹232.9 as of 09 May ‘25
Denis Chem Lab Ltd's CAGR for 5 Years at 22.67%, 3 Years at 17.08%, 1 Year at -55.46%, 6 Month at -39.26%, 3 Month at -33.65% and 1 Month at 3.42%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.